The six amino acid antimicrobial peptide bLFcin6 penetrates cells and delivers siRNA

FEBS Journal

Volumn 280, Issue 4, 2013, Pages 1007-1017

  Fang, Bing ^a,b,c   Guo, Hui Y ^a,c   Zhang, Ming ^a,b   Jiang, Lu ^a,b   Ren, Fa Z ^a,b,c  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b Beijing Higher Institution Engineering Research Center of Animal Product   (China)

^c Beijing Key Laboratory of Nutrition   (China)

Author keywords

antimicrobial peptide; bovine lactoferricin; cell penetrating peptide; siRNA

Indexed keywords

BOVINE LACTOFERRICIN RESIDUE 4-9; CELL PENETRATING PEPTIDE; CELL PENETRATING PEPTIDE 5; CELL PENETRATING PEPTIDE 6; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; LACTOFERRICIN; SMALL INTERFERING RNA; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID ANALYSIS; ARTICLE; CELL MEDIATED CYTOTOXICITY; CONCENTRATION RESPONSE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FLOW CYTOMETRY; GENE INACTIVATION; INTERNALIZATION; LIPID RAFT; MOLECULAR BIOLOGY; MOLECULAR WEIGHT; NONHUMAN; PINOCYTOSIS; PRIORITY JOURNAL; PROTEIN TRANSPORT; RNA TRANSPORT;

ANIMALS; ANTI-INFECTIVE AGENTS; CATTLE; CELL NUCLEUS; CELL SURVIVAL; CYTOPLASM; GENE KNOCKDOWN TECHNIQUES; GENE TRANSFER TECHNIQUES; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HELA CELLS; HUMANS; LACTOFERRIN; PEPTIDE FRAGMENTS; RNA INTERFERENCE; RNA, SMALL INTERFERING;

BOVINAE;

EID: 84874116781     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.12093     Document Type: Article

References (75)

1. Saar K, Lindgren M, Hansen M, Eiríksdõttir E, Jiang Y, Rosenthal-Aizman K, Sassian M, &, Langel Ü, (2005) Cell-penetrating peptides: a comparative membrane toxicity study. Anal Biochem 34, 555-565.
2. Lu S, Tager LA, Chitale S, &, Riley LW, (2006) A cell-penetrating peptide derived from mammalian cell uptake protein of Mycobacterium tuberculosis. Anal Biochem 353, 7-14.
3. Snyder EL, &, Dowdy SF, (2004) Cell penetrating peptides in drug delivery. Pharm Res 21, 389-393.
4. Wadia JS, &, Dowdy SF, (2005) Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer. Adv Drug Deliv Rev 57, 579-596.
5. Gait MJ, (2003) Peptide-mediated cellular delivery of antisense oligonucleotides and their analogues. Cell Mol Life Sci 60, 844-853.
6. Eguchi A, Akuta T, Okuyama H, Senda T, Yokoi H, Inokuchi H, Fujita S, Hayakawa T, Takeda K, Hasegawa M, et al,. (2001) Protein transduction domain of HIV-1 Tat protein promotes efficient delivery of DNA into mammalian cells. J Biol Chem 276, 26204-26210.
7. Torchilin VP, Rammohan R, Weissig V, &, Levchenko TS, (2001) TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc Natl Acad Sci USA 98, 8786-8791.
8. Torchilin VP, Levchenko TS, Rammohan R, Volodina N, Papahadjopoulos- Sternberg B, &, D'Souza GG, (2003) Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes. Proc Natl Acad Sci USA 100, 1972-1977.
9. Lewin M, Carlesso N, Tung CH, Tang XW, Cory D, Scadden DT, &, Wessleder R, (2000) Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol 18, 410-414.
10. Milletti F, (2012) Cell-penetrating peptides: classes, origin, and current landscape. Drug Discov Today, 17, 850-860.
11. Johansson HJ, El-Andaloussi S, Holm T, Mäe M, Jänes J, Maimets T, &, Langel U, (2007) Characterization of a novel cytotoxic cell-penetrating peptide derived from p14ARF protein. Mol Ther 16, 115-123.
12. Futaki S, Suzuki T, Ohashi W, Yagami T, Tanaka S, Ueda K, &, Sugiura Y, (2001) Arginine-rich peptides, an abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J Biol Chem 276, 5836-5840.
13. Pooga M, Hallbrink M, Zorko M, &, Langel U, (1998) Cell penetration by transportan. FASEB J 12, 67-77.
14. Green M, Ishino M, &, Loewenstein PM, (1989) Mutational analysis of HIV-1 Tat minimal domain peptides: identification of trans-dominant mutants that suppress HIV-LTR-driven gene expression. Cell 58, 215-223.
15. Derossi D, Calvet S, Trembleau A, Brunissen A, Chassaing G, &, Prochiantz A, (1996) Cell internalization of the third helix of the antennapedia homeodomain is receptor-independent. J Biol Chem 271, 18188-18193.
16. Tünnemann G, Ter-Avetisyan G, Martin RM, Stöckl M, Herrmann A, &, Cardoso MC, (2008) Live-cell analysis of cell penetration ability and toxicity of oligo-arginines. J Pept Sci 14, 469-476.
17. Elmquist A, Lindgren M, Bartfai T, &, Langel U, (2001) VE-cadherin-derived cell-penetrating peptide, pVEC, with carrier functions. Exp Cell Res 269, 237-244.
18. Morris MC, Vidal P, Chaloin L, Heitz F, &, Divita G, (1997) A new peptide vector for efficient delivery of oligonucleotides into mammalian cells. Nucleic Acids Res 25, 2730-2736.
19. Morris MC, Depollier J, Mery J, Heitz F, &, Divita G, (2001) A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat Biotechnol 19, 1173-1176.
20. Gao C, Mao S, Ditzel HJ, Farnaes L, Wirsching P, Lerner RA, &, Janda KD, (2002) A cell-penetrating peptide from a novel pVII-pIX phage-displayed random peptide library. Bioorg Med Chem 10, 4057-4065.
21. Wang YF, Xu X, Fan X, Zhang C, Wei Q, Wang X, Guo W, Xing W, Yu J, Yan JL, et al,. (2011) A cell-penetrating peptide suppresses inflammation by inhibiting NF-κB signaling. Mol Ther 19, 1849-1857.
22. Yoshida T, Tomioka I, Nagahara T, Holyst T, Sawada M, Hayes P, Gama V, Okuno M, Chen Y, Abe Y, et al,. (2004) Bax-inhibiting peptide derived from mouse and rat Ku70. Biochem Biophys Res Commun 321, 961-966.
23. Gomez JA, Gama V, Yoshida T, Sun W, Hayes P, Leskov K, Boothman D, &, Matsuyama S, (2007) Bax-inhibiting peptides derived from Ku70 and cell-penetrating pentapeptides. Biochem Soc Trans 35, 797-801.
24. Rhee M, &, Davis P, (2006) Mechanism of uptake of C105Y, a novel cell-penetrating peptide. J Biol Chem 281, 1233-1240.
25. Splith K, &, Neundorf I, (2011) Antimicrobial peptides with cell-penetrating peptide properties and vice versa. Eur Biophys J 40, 387-397.
26. Nekhotiaeva N, Elmquist A, Rajarao GK, Hällbrink M, Langel U, &, Good L, (2004) Cell entry and antimicrobial properties of eukaryotic cell-penetrating peptides. FASEB J 18, 394-396.
27. Smith BA, Daniels DS, Coplin AE, Jordan GE, McGregor LM, &, Schepartz A, (2008) Minimally cationic cell-permeable miniature proteins via α-helical arginine display. J Am Chem Soc 130, 2948-2949.
28. Otvos L Jr, Cudic M, Chua BY, Deliyannis G, &, Jackson DC, (2004) An insect antibacterial peptide-based drug delivery system. Mol Pharm 1, 220-232.
29. Kerkis A, Kerkis I, Rádis-Baptista G, Oliveira EB, Vianna-Morgante AM, Pereira LV, &, Yamane T, (2004) Crotamine is a novel cell-penetrating protein from the venom of rattlesnake Crotalus durissus terrificus. FASEB J 18, 1407-1409.
30. Kobayashi S, Takeshima K, Park CB, Kim SC, &, Matsuzaki K, (2000) Interactions of the novel antimicrobial peptide buforin 2 with lipid bilayers: proline as a translocation promoting factor. Biochemistry 39, 8648-8654.
31. Duchardt F, Ruttekolk IR, Verdurmen WPR, Lortat-Jacob H, Bürck J, Hufnagel H, Fischer R, van den Heuvel M, Löwik DWPM, Vuister GW, et al,. (2009) A cell-penetrating peptide derived from human lactoferrin with conformation-dependent uptake efficiency. J Biol Chem 284, 36099-36108.
32. Bellamy W, Takase M, Wakabayashi H, Kawase K, &, Tomita M, (1992) Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin. J Appl Bacteriol 73, 472-479.
33. Wakabayashi H, Hiratani T, Uchida K, &, Yamaguchi H, (1996) Anti-fungal spectrum and fungicidal mechanism of an N-terminal peptide of bovine lactoferrin. J Infect Chemother 1, 185-189.
34. Schibli DJ, Hwang PM, &, Vogel HJ, (1999) The structure of the antimicrobial active center of lactoferricin B bound to sodium dodecyl sulfate micelles. FEBS Lett 446, 213-217.
35. Bellamy W, Wakabayashi H, Takase M, Kawase K, Shimamura S, &, Tomita M, (1993) Role of cell binding in the antibacterial mechanism of lactoferricin B. J Appl Bacteriol 75, 478-484.
36. Vogel HJ, Schibli DJ, Jing W, Lohmeier-Vogel EM, Epand RF, &, Epand RM, (2002) Towards a structure-function analysis of bovine lactoferricin and related tryptophan- and arginine-containing peptides. Biochem Cell Biol 80, 49-63.
37. Bellamy W, Takase M, Yamauchi K, Wakabayashi H, Kawase K, &, Tomita M, (1992) Identification of the bactericidal domain of lactoferrin. Biochim Biophys Acta 1121, 130-136.
38. Chan DI, Prenner EJ, &, Vogel HJ, (2006) Tryptophan- and arginine-rich antimicrobial peptides: structures and mechanisms of action. Biochim Biophys Acta 1758, 1184-1202.
39. Fillon YA, Anderson JP, &, Chmielewski J, (2005) Cell penetrating agents based on a polyproline helix scaffold. J Am Chem Soc 127, 11798-11803.
40. Geisler I, &, Chmielewski J, (2009) Cationic amphiphilic polyproline helices: side-chain variations and cell-specific internalization. Chem Biol Drug Des 73, 39-45.
41. Martín I, Teixidõ M, &, Giralt E, (2011) Design, synthesis and characterization of a new anionic cell-penetrating peptide: SAP(E). ChemBioChem 12, 896-903.
42. Tomita M, Takase M, Bellamy W, &, Shimamura S, (1994) A review: the active peptide of lactoferrin. Acta Paediatr Jpn 36, 585-591.
43. Ueta E, Tanida T, &, Osaki T, (2001) A novel bovine lactoferrin peptide, FKCRRWQWRM, suppresses Candida cell growth and activates neutrophils. J Pept Res 57, 240-249.
44. Kang JH, Lee MK, Kim KL, &, Hahm KS, (1996) Structure-biological activity relationships of 11-residue highly basic peptide segment of bovine lactoferrin. Int J Pept Protein Res 48, 357-363.
45. Strom MB, Rekdal O, &, Svendsen JS, (2000) Antibacterial activity of 15-residue lactoferricin derivatives. J Pept Res 56, 265-274.
46. Wakabayashi H, Matsumoto H, Hashimoto K, Teraguchi S, Takase M, &, Hayasawa H, (1999) N-Acylated and d enantiomer derivatives of a nonamer core peptide of lactoferricin B showing improved antimicrobial activity. Antimicrob Agents Chemother 43, 1267-1269.
47. Hwang PM, Zhou N, Shan X, Arrowsmith CH, &, Vogel HJ, (1998) Three-dimensional solution structure of lactoferricin B, an antimicrobial peptide derived from bovine lactoferrin. Biochemistry 37, 4288-4298.
48. Nguyen LT, Chau JK, Perry NA, de Boer L, Zaat SAJ, &, Vogel HJ, (2010) Serum stabilities of short tryptophan- and arginine-rich antimicrobial peptide analogs. PLoS ONE 5, e12684.
49. Prochiantz A, (1996) Getting hydrophilic compounds into cells: lessons from homeopeptides. Curr Opin Neurobiol 6, 629-634.
50. Morris MC, Deshayes S, Heitz F, &, Divita G, (2008) Cell-penetrating peptides: from molecular mechanisms to therapeutics. Biol Cell 100, 201-217.
51. Fimland G, Eijsink VG, &, Nissen-Meyer J, (2002) Mutational analysis of the role of tryptophan residues in an antimicrobial peptide. Biochemistry 41, 9508-9515.
52. Schibli DJ, Epand RF, Vogel HJ, &, Epand RM, (2002) Tryptophan-rich antimicrobial peptides: comparative properties and membrane interactions. Biochem Cell Biol 80, 667-677.
53. Killian JA, &, von Heijne G, (2000) How proteins adapt to a membrane-water interface. Trends Biochem Sci 25, 429-434.
54. Muratovska A, &, Eccles MR, (2004) Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells. FEBS Lett 558, 63-75.
55. Davidson TJ, Harel S, Arboleda VA, Prunell GF, Shelanski ML, Greene LA, &, Troy CM, (2004) Highly efficient small interfering RNA delivery to primary mammalian neurons induces microRNA-like effects before mRNA degradation. J Neurosci 24, 10040-10046.
56. Soutschek J, Akinc A, Bramlage B, Charisse K, Constien R, Donoghue M, Elbashir S, Geick A, Hadwiger P, Harborth J, et al,. (2004) Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 432, 173-178.
57. Wender PA, Mitchell DJ, Pattabiraman K, Pelkey ET, Steinman L, &, Rothbard JB, (2000) The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc Natl Acad Sci USA 97, 13003-13008.
58. Orzáez M, Mondragõn L, Marzo I, Sanclimens G, Messeguer À, Pérez-Payá E, &, Vicent MJ, (2007) Conjugation of a novel Apaf-1 inhibitor to peptide-based cell-membrane transporters: effective methods to improve inhibition of mitochondria-mediated apoptosis. Peptides 28, 958-968.
59. Hunter HN, Jing W, Schibli DJ, Trinh T, Park IY, Kim SC, &, Vogel HJ, (2005) The interactions of antimicrobial peptides derived from lysozyme with model membrane systems. Biochim Biophys Acta 1668, 175-189.
60. Nguyen LT, Schibli DJ, &, Vogel HJ, (2005) Structural studies and model membrane interactions of two peptides derived from bovine lactoferricin. J Pept Sci 11, 379-389.
61. 2 with model membrane systems and bacterial cells. J Pept Res 65, 491-501.
62. Vives E, Richard JP, Rispal C, &, Lebleu B, (2003) TAT peptide internalization: seeking the mechanism of entry. Curr Protein Pept Sci 4, 125-132.
63. Silhol M, Tyagi M, Giacca M, Lebleu B, &, Vives E, (2002) Different mechanisms for cellular internalization of the HIV-1 Tat-derived cell penetrating peptide and recombinant proteins fused to Tat. Eur J Biochem 269, 494-501.
64. Wadia JS, Stan RV, &, Dowdy SF, (2004) Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat Med 10, 310-315.
65. Console S, Marty C, Garcia-Echeverria C, Schwendener R, &, Ballmer-Hofer K, (2003) Antennapedia and HIV TAT 'protein transduction domains' promote endocytosis of high molecular weight cargo upon binding to cell surface glycosaminoglycans. J Biol Chem 278, 35109-35114.
66. Lundberg M, Wikstrom S, &, Johansson M, (2003) Cell surface adherence and endocytosis of protein transduction domains. Mol Ther 8, 143-150.
67. Fittipaldi A, Ferrari A, Zoppé M, Arcangeli C, Pellegrini V, Beltram F, &, Giacca M, (2003) Cell membrane lipid rafts mediate caveolar endocytosis of HIV-1 tat fusion proteins. J Biol Chem 278, 34141-34149.
68. Perret F, Nishihara M, Takeuchi T, Futaki S, Lazar AN, Coleman AW, Sakai N, &, Matile S, (2005) Anionic fullerenes, calixarenes, coronenes, and pyrenes as activators of oligo/polyarginines in model membranes and live cells. J Am Chem Soc 127, 1114-1115.
69. Takeuchi T, Kosuge M, Tadokoro A, Sugiura Y, Nishi M, Kawata M, Sakai N, Matile S, &, Futaki S, (2006) Direct and rapid cytosolic delivery using cell-penetrating peptides mediated by pyrenebutyrate. ACS Chem Biol 1, 299-303.
70. Anderson RG, (1998) The caveolae membrane system. Annu Rev Biochem 67, 199-225.
71. Nichols BJ, &, Lippincott-Schwartz J, (2001) Endocytosis without clathrin coats. Trends Cell Biol 11, 406-412.
72. Jo D, Nashabi A, Doxsee C, Lin Q, Unutmaz D, Chen J, &, Ruley HE, (2001) Epigenetic regulation of gene structure and function with a cell-permeable Cre recombinase. Nat Biotechnol 19, 929-933.
73. Schwarze SR, Ho A, Vocero-Akbani A, &, Dowdy SF, (1999) In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285, 1569-1572.
74. Felicea DL, Sun J, &, Liu RH, (2009) A modified methylene blue assay for accurate cell counting. J Funct Foods 1, 109-118.
75. Jin J, Liu S, Zhao L, Ge K, Mao X, &, Ren F, (2011) Changes in ffh, uvrA, groES and dnaK mRNA abundance as a function of acid-adaptation and growth phase in Bifidobacterium longum BBMN68 isolated from healthy centenarians. Curr Microbiol 62, 612-617.